News

Early Zoledronic Acid Beats Late for AI Bone Loss

Publish date: February 15, 2008
PDF Download

 

Z-FAST was sponsored by Novartis Oncology.

Dr. Brufsky and Dr. Hadji are on the speakers bureau for Novartis.

'I'm not certain that every woman should get these drugs, but I'm becoming more convinced of that.' DR. BRUFSKY

Pages

Recommended Reading

Use Histology to Confirm Endometriosis Diagnosis
MDedge ObGyn
Breast Cancer Leads Mortality Drop in U.S., U.K.
MDedge ObGyn
Weight Gain After Breast Cancer Diagnosis Ups Mortality Risk
MDedge ObGyn
IVF Sperm Origin No Factor in Cognitive Risks
MDedge ObGyn
PGD Aids Women With Past Miscarriages
MDedge ObGyn
Cutting Anthracycline Use in Breast Ca Debated
MDedge ObGyn
Breast Tomosynthesis May Reduce Recall Rates
MDedge ObGyn
DMPA Users' Endometritis Tied To Inflammation, Not Infection
MDedge ObGyn
Fewer Adverse Events With Cyclic OCs After Endometrioma Excision
MDedge ObGyn
Added Calcium Raises MI Risk in Older Women
MDedge ObGyn